Metraipolis › archive › dc_58b0b87daebb
Selective SIK2/SIK3 inhibition reprograms pro- and antiinflammatory pathways in myeloid cells, improving autoimmune disease outcomes — Europe PMC PMID:41657312
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41657312
- DOI
- 10.1172/jci.insight.171776
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T00:36:16.691Z
- SHA-256 of the archived text
26741914bf3cf57a9b152ec3c344eef660b4edc4ebabd235e82f20f639e496d0- Stable URL of this page
https://metraipolis.com/documento/dc_58b0b87daebb
How to cite
Selective SIK2/SIK3 inhibition reprograms pro- and antiinflammatory pathways in myeloid cells, improving autoimmune disease outcomes — Europe PMC PMID:41657312 — Europe PMC (en), https://europepmc.org/article/MED/41657312 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_58b0b87daebb (Metraipolis archive dc_58b0b87daebb, sha256 26741914bf3cf57a9b152ec3c344eef660b4edc4ebabd235e82f20f639e496d0)
BibTeX
@misc{dc58b0b87daebb,
title = {Selective SIK2/SIK3 inhibition reprograms pro- and antiinflammatory pathways in myeloid cells, improving autoimmune disease outcomes — Europe PMC PMID:41657312},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41657312},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_58b0b87daebb; sha256 26741914bf3cf57a9b152ec3c344eef660b4edc4ebabd235e82f20f639e496d0},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41657312. Agents can read the archived copy with the MCP tool read_document.